Browsing Tag
4DMedical
9 posts
4DMedical (ASX: 4DX) stock up 7.3% as Mayo Clinic adoption and GSK contract reset lung imaging story
Nuclear medicine VQ scans are a US$1 billion market. 4DMedical (ASX: 4DX) just landed Mayo Clinic, GSK, and Medicare. The question is now scan volume scaling speed.
CSL (ASX: CSL) crashes 17.7% to A$98.59 after FY26 guidance cut and $5bn impairments
CSL cut FY26 NPATA to US$3.1 billion and flagged US$5 billion in impairments. The third downgrade in ten months is repricing the entire ASX healthcare sector.
4DMedical (ASX: 4DX) secures CE Mark for CT:VQ and raises A$83m to accelerate European commercial launch
4DMedical (ASX: 4DX) secures CE Mark for CT:VQ and raises A$83M to fund EU expansion. Read what this means for investors and the respiratory imaging sector.
4DMedical raises (ASX:4DX) $150m to fuel U.S. lung imaging push and expand AI respiratory portfolio
4DMedical raises $150M to scale CT:VQ in the U.S. with minimal dilution. Find out how this move sets the stage for profitability and market leadership.
4DMedical’s CT:VQ clearance could mark the end of nuclear VQ scans—is the industry ready for software-first lung imaging?
4DMedical’s FDA-cleared CT:VQ may replace nuclear lung scans with software-powered diagnostics. Explore how this breakthrough is reshaping imaging standards.
How 4DMedical’s CT:VQ is rewriting the rules of lung imaging—no radiotracers, no waiting rooms, just pixels
CT:VQ gets FDA clearance—and 4DMedical may be the new standard in lung imaging. Discover how this Aussie SaaS medtech is reshaping respiratory diagnostics.
Why 4DMedical stock is suddenly soaring—and how FDA approval could open a billion-dollar market
4DMedical stock jumps 35% as CT:VQ earns FDA clearance. Find out how this breakthrough in lung imaging is reshaping the USD $1.1B VQ scan market.
Philips to distribute 4DMedical’s cutting-edge lung health technology across U.S.
In a monumental move set to shake up the U.S. healthcare industry, 4DMedical has just announced a comprehensive…
4DMedical expands XV LVAS scans to Detroit and Memphis imaging facilities
4DMedical Limited (ASX: 4DX), a renowned respiratory imaging technology company, has entered into agreements to deliver its XV…